These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 22468818)

  • 41. Molecular genetics of head and neck cancer.
    Sidransky D
    Curr Opin Oncol; 1995 May; 7(3):229-33. PubMed ID: 7654824
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An introduction to molecular pathology of the head and neck.
    Hunt JL
    Arch Pathol Lab Med; 2014 Jun; 138(6):730. PubMed ID: 24878012
    [No Abstract]   [Full Text] [Related]  

  • 43. Role of DNA methylation in head and neck cancer.
    Demokan S; Dalay N
    Clin Epigenetics; 2011 Aug; 2(2):123-50. PubMed ID: 22704334
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ploidy in head and neck cancer: a review and meta-analysis.
    Stell PM
    Clin Otolaryngol Allied Sci; 1991 Oct; 16(5):510-6. PubMed ID: 1835912
    [No Abstract]   [Full Text] [Related]  

  • 45. Proceedings of the 3rd European Workshop on Basic Biology of Head and Neck Cancer: Finding Consensus on the Use of Prognostic Factors and Predictive Markers. Oslo, Norway, 28-31 August 1997.
    Anticancer Res; 1998; 18(6B):4727-806. PubMed ID: 9935385
    [No Abstract]   [Full Text] [Related]  

  • 46. [Current methods in molecular pathology].
    Hench J; Jermann PM; Bratic Hench I; Matter MS
    Ther Umsch; 2019 Sep; 76(4):173-178. PubMed ID: 31498035
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TP53-Associated Ion Channel Genes Serve as Prognostic Predictor and Therapeutic Targets in Head and Neck Squamous Cell Carcinoma.
    Sun J; Yu X; Xue L; Li S; Li J; Tong D; Du Y
    Technol Cancer Res Treat; 2020; 19():1533033820972344. PubMed ID: 33243093
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The immunoregulatory protein B7-H3 promotes aerobic glycolysis in oral squamous carcinoma via PI3K/Akt/mTOR pathway.
    Li Z; Liu J; Que L; Tang X
    J Cancer; 2019; 10(23):5770-5784. PubMed ID: 31737114
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Promoter Hypermethylation of Tumor-Suppressor Genes
    Liyanage C; Wathupola A; Muraleetharan S; Perera K; Punyadeera C; Udagama P
    Biomolecules; 2019 Apr; 9(4):. PubMed ID: 31013839
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lymph node ratio is associated with adverse clinicopathological features and is a crucial nodal parameter for oral and oropharyngeal cancer.
    Feng Z; Xu QS; Wang C; Li JZ; Mao MH; Li H; Qin LZ; Han Z
    Sci Rep; 2017 Jul; 7(1):6708. PubMed ID: 28751709
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blockage of glycolysis by targeting PFKFB3 suppresses tumor growth and metastasis in head and neck squamous cell carcinoma.
    Li HM; Yang JG; Liu ZJ; Wang WM; Yu ZL; Ren JG; Chen G; Zhang W; Jia J
    J Exp Clin Cancer Res; 2017 Jan; 36(1):7. PubMed ID: 28061878
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dual induction of apoptotic and autophagic cell death by targeting survivin in head neck squamous cell carcinoma.
    Zhang L; Zhang W; Wang YF; Liu B; Zhang WF; Zhao YF; Kulkarni AB; Sun ZJ
    Cell Death Dis; 2015 May; 6(5):e1771. PubMed ID: 26018732
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
    Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
    J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantitative iTRAQ LC-MS/MS Proteomics Reveals Transcription Factor Crosstalk and Regulatory Networks in Hypopharyngeal Squamous Cell Carcinoma.
    Zhu G; Cai G; Liu Y; Tan H; Yu C; Huang M; Wei M; Li S; Cui X; Huang D; Tian Y; Zhang X
    J Cancer; 2014; 5(7):525-36. PubMed ID: 24963357
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SLC23A2-05 (rs4987219) and KRAS-LCS6 (rs61764370) polymorphisms in patients with squamous cell carcinoma of the head and neck.
    Santiago MB; DE Lima Marson FA; Secolin R; Ribeiro JD; Lima CS; Bertuzzo CS
    Oncol Lett; 2014 Jun; 7(6):1803-1811. PubMed ID: 24932237
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral cancer: current status of molecular biology and treatment strategy.
    Kirita T
    Int J Clin Oncol; 2014; 19(3):421-2. PubMed ID: 24639019
    [No Abstract]   [Full Text] [Related]  

  • 57. Epigenetic and genetic alterations-based molecular classification of head and neck cancer.
    Feng Z; Xu Q; Chen W
    Expert Rev Mol Diagn; 2012 Apr; 12(3):279-90. PubMed ID: 22468818
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
    De Schutter H; Geeraerts H; Verbeken E; Nuyts S
    Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Therapeutic exploitation of the physiological and molecular genetic alterations in head and neck cancer.
    Le QT; Giaccia AJ
    Clin Cancer Res; 2003 Oct; 9(12):4287-95. PubMed ID: 14555497
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biological agents in head and neck cancer.
    Bossi P; Locati LD; Licitra L
    Expert Rev Anticancer Ther; 2007 Nov; 7(11):1643-50. PubMed ID: 18020930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.